NEW YORK, July 27, 2015 /PRNewswire/ -- Small Cap IR -- That Marketing Solution Inc. (OTCQB: TSTS) is a developer and marketer of health related products and owner of the proprietary Aqua V Micellization process, announced that the company has received the first order to produce two different products totaling $68,000. This is a huge step forward to the company that is currently not reporting any revenue. With second quarter financial results not providing much comfort for investors, the stage has been set for TSTS to impress with its third and fourth quarter financials for 2015. Should revenue be recorded, the stock price could see corresponding appreciation.
About That Marketing Solution Inc.:
That Marketing Solution develops and markets health related products. The company owns and operates technology around the Micellization Manufacturing Process. This Proprietary Micellization Process converts oil-based nutrients into water-soluble products for better absorption by the cells.
About TSTS's Aqua V Technology:
The Aqua V Technology is an important scientific discovery that exponentially increases the nutritional benefits of bio-nutrients to the body, while lowering the amount of raw ingredients required to manufacture the nutritional formula. Many of the most important bio-nutrients that people supplement in their diets are fat-soluble. Therefore, the body must micellize the supplement by breaking it down -- which leaves only a portion of the bio-nutrient available for uptake. By using this proprietary technology to adapt the nutrient outside of the body, the uptake is almost immediate, and the formulation has almost no bio-waste in the process. This allows formulators to use less active ingredient in their formulas to get the maximum benefit, and, it controls the delivery of the exact amount of nutritional value to the body.
For a more detailed research report with analyst comments and recommendation on That Marketing Solution Inc. please follow the link. There is no cost obligation required to view analyst brief.
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
Content is researched, written and reviewed on a best-effort basis. This report was prepared for informational purposes only. Affiliated parties involved with producing and issuing this report have not been compensated in any form by profiled company. A full disclaimer can be found by viewing the full analyst report. This document, article or report is written and authored by a 3rd party research analyst. However, we are only human and may make mistakes. If you notice any errors or omissions, please notify us below.
NOT FINANCIAL ADVICE
Small Cap IR makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
SOURCE Small Cap IR